Last updated: June 21, 2023
Sponsor: Tanta University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Ankylosing Spondylitis
Treatment
medical ozone
methylprednisolone acetate and lidocaine
PRP and lidocaine
Clinical Study ID
NCT05914350
36264MD46/3/23
Ages 21-65 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- One hundred and five patients, ASA physical status I - III, age 21 - 65 years, diagnosedwith sacroiliitis.
Exclusion
Exclusion Criteria:
- • Patient refusal
- Psychological disturbance.
- Local skin infection at the site of injection.
- Ozone allergy
- Coagulation disorders.
- Chronic opioid use.
- Sacroiliitis associated with disk pathology.
- Severe ankylosing spondylitis.
- History of corticosteroid injection within last three months.
- Uncontrolled concomitant medical condition.
- Severe arrhythmia, hypertensive crisis and other cardiovascular diseases.
- Pregnant women.
- Bowel inflammatory disease.
- Psoriasis
Study Design
Total Participants: 105
Treatment Group(s): 4
Primary Treatment: medical ozone
Phase:
Study Start date:
June 23, 2023
Estimated Completion Date:
March 23, 2025
Study Description
Connect with a study center
Tanta University hospitals
Tanta, 31527
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.